TABLE 1.
KDHP (pM) | KCaC (%M) | % | |
---|---|---|---|
Wild-type | 367 ± 19 | 0.322 ± 0.055 | 0.48 ± 0.05 |
Mut A | 1660 ± 120 * | 0.344 ± 0.065 | ~1 * |
Mut B | 391 ± 52 | 0.216 ± 0.024 | 0.45 ± 0.05 |
Mut C | 460 ± 50 | n.d. | n.d. |
E1122A | 294 ± 42 | 1.14 ± 0.20 * | n.d. |
D1127A | 511 ± 53 | 1.61 ± 0.94 * | 0.75 ± 0.07 * |
D1129A | 289 ± 80 | 21.0 ± 6.0 * | n.d. |
KDHP values were determined by [3H]-PN200-110 binding in the absence of calcicludine, as described in Fig. 2. KCaC values were determined using whole-cell patch-clamp electrophysiology, as described in Figs 4–5. Values for the cooperativity factor alpha (α) for wild-type, Mut A and Mut B were determined by fitting the data depicted in Fig. 3. Mut C proved to be insensitive to calcicludine, so KCaC and α for this mutant were “not determined” (n.d.). Binding data from E1122A and D1129A were fit using the mutants’ respective KDHP and KCaC values and a value for α equal to that of wild-type (i.e., 0.48). In contrast to E1122A and D1129A, it was necessary to adjust α to 0.75 to achieve a reasonable fit for D1127A.
; P<0.05.